Topotecan induced nail pigmentation.
Baykal
Yeşim
Y
Baykal
Cem
C
Ozer
Suha
S
Tulunay
Gökhan
G
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002291:Carcinoma, Papillary / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D009260:Nail Diseases / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D019772:Topotecan / Q000009:adverse effects*
D000970:Antineoplastic Agents; D019772:Topotecan